Clinical Trial Update: Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating everolimus, temozolomide, and radiation therapy for newly diagnosed glioblastoma multiforme (Phase 1/2) completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Everolimus (everolimus)
• Radiation therapy
• Temozolomide (Temozolomide)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-01-23